CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
135 hedge funds and large institutions have $718M invested in Clovis Oncology, Inc. in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
49% less capital invested
Capital invested by funds: $1.39B → $718M (-$677M)
49% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 41
Holders
135
Holding in Top 10
5
Calls
$70.5M
Puts
$36.6M
Top Buyers
| 1 | +$25M | |
| 2 | +$9.9M | |
| 3 | +$9.12M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$6.67M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.03M |
Top Sellers
| 1 | -$30.1M | |
| 2 | -$24.8M | |
| 3 | -$17M | |
| 4 |
Goldman Sachs
New York
|
-$16.3M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$4.05M |